Patents by Inventor Renee Barber

Renee Barber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of assessing a risk of developing necrotizing meningoencephalitis
    Patent number: 10770183
    Abstract: The present invention provides method of classifying a subject into a necrotizing meningoencephalitis (NME) disease risk group. The method may include assessing the presence of one or more marker (e.g., SNPs or risk loci) in a sample from the subject. For example, detection of the presence of one or more markers that are associated with an increased risk of NME can indicate that the subject should be classified into a risk group.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: September 8, 2020
    Assignees: The Translational Genomics Research Institute, University of Georgia Research Foundation, Inc.
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber
  • METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS
    Publication number: 20190051418
    Abstract: The present invention provides method of classifying a subject into a necrotizing meningoencephalitis (NME) disease risk group. The method may include assessing the presence of one or more marker (e.g., SNPs or risk loci) in a sample from the subject. For example, detection of the presence of one or more markers that are associated with an increased risk of NME can indicate that the subject should be classified into a risk group.
    Type: Application
    Filed: October 22, 2018
    Publication date: February 14, 2019
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber
  • Methods of assessing a risk of developing necrotizing meningoencephalitis
    Patent number: 10147505
    Abstract: The present invention provides method of classifying a subject into a necrotizing meningoencephalitis (NME) disease risk group. The method may include assessing the presence of one or more marker (e.g., SNPs or risk loci) in a sample from the subject. For example, detection of the presence of one or more markers that are associated with an increased risk of NME can indicate that the subject should be classified into a risk group.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: December 4, 2018
    Assignees: The Translational Genomics Research Institute, University of Georgia Research Foundation, Inc.
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber
  • METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS
    Publication number: 20150347703
    Abstract: The present invention provides method of classifying a subject into a necrotizing meningoencephalitis (NME) disease risk group. The method may include assessing the presence of one or more marker (e.g., SNPs or risk loci) in a sample from the subject. For example, detection of the presence of one or more markers that are associated with an increased risk of NME can indicate that the subject should be classified into a risk group.
    Type: Application
    Filed: May 15, 2015
    Publication date: December 3, 2015
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber
  • METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS
    Publication number: 20130323733
    Abstract: Methods of using single nucleotide polymorphisms (SNPs), SNP haplotype block, and haplotype to predict whether or not a subject will develop necrotizing meningoencephalitis (NME) and probe sets that facilitate those methods are disclosed. In preferred forms, the subject is a canine species.
    Type: Application
    Filed: May 29, 2013
    Publication date: December 5, 2013
    Applicant: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber, Jason Corneveaux
  • METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS
    Publication number: 20130157873
    Abstract: Methods of using single nucleotide polymorphisms (SNPs), SNP haplotype block, and haplotype to predict whether or not a subject will develop necrotizing meningoencephalitis (NME) and probe sets that facilitate those methods are disclosed. In particular, the subject is a canine species.
    Type: Application
    Filed: May 19, 2011
    Publication date: June 20, 2013
    Applicant: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Matthew Huentelman, Scott Schatzberg, Renee Barber